![Patients with CA 19-9 > 37 U/ml in different tumor grades, depth of... | Download Scientific Diagram Patients with CA 19-9 > 37 U/ml in different tumor grades, depth of... | Download Scientific Diagram](https://www.researchgate.net/publication/225044947/figure/tbl2/AS:202694657613825@1425337580026/Patients-with-CA-19-9-37-U-ml-in-different-tumor-grades-depth-of-invasion-and-in.png)
Patients with CA 19-9 > 37 U/ml in different tumor grades, depth of... | Download Scientific Diagram
![Prognostic value of tumor markers and ctDNA in patients with resectable gastric cancer receiving perioperative treatment: results from the CRITICS trial | SpringerLink Prognostic value of tumor markers and ctDNA in patients with resectable gastric cancer receiving perioperative treatment: results from the CRITICS trial | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10120-021-01258-6/MediaObjects/10120_2021_1258_Fig4_HTML.png)
Prognostic value of tumor markers and ctDNA in patients with resectable gastric cancer receiving perioperative treatment: results from the CRITICS trial | SpringerLink
![SciELO - Brasil - Preoperative serum levels of ca 72-4, cea, ca 19-9, and Alpha-fetoprotein in patients with gastric cancer Preoperative serum levels of ca 72-4, cea, ca 19-9, and Alpha-fetoprotein in SciELO - Brasil - Preoperative serum levels of ca 72-4, cea, ca 19-9, and Alpha-fetoprotein in patients with gastric cancer Preoperative serum levels of ca 72-4, cea, ca 19-9, and Alpha-fetoprotein in](https://minio.scielo.br/documentstore/1678-9903/GbJpRsRZcNGws7b5bgPP8vc/ef6d70eda1098ff0140f9326c19031a935741531.gif)
SciELO - Brasil - Preoperative serum levels of ca 72-4, cea, ca 19-9, and Alpha-fetoprotein in patients with gastric cancer Preoperative serum levels of ca 72-4, cea, ca 19-9, and Alpha-fetoprotein in
![Table 3 from Tumor markers CA 19-9 , CA 242 and CEA in the diagnosis of pancreatic cancer : a meta-analysis | Semantic Scholar Table 3 from Tumor markers CA 19-9 , CA 242 and CEA in the diagnosis of pancreatic cancer : a meta-analysis | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/9e4b5e3558e03a39c0abef98e9e7edcf83b79f60/6-Table3-1.png)
Table 3 from Tumor markers CA 19-9 , CA 242 and CEA in the diagnosis of pancreatic cancer : a meta-analysis | Semantic Scholar
![CA19–9 decrease and survival according to platelet level in patients with advanced pancreatic cancer | BMC Cancer | Full Text CA19–9 decrease and survival according to platelet level in patients with advanced pancreatic cancer | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-019-6078-2/MediaObjects/12885_2019_6078_Fig1_HTML.png)
CA19–9 decrease and survival according to platelet level in patients with advanced pancreatic cancer | BMC Cancer | Full Text
Serum CA19-9 Is Significantly Upregulated up to 2 Years before Diagnosis with Pancreatic Cancer: Implications for Early Disease
Columbia Asia Malaysia - Cancer Markers Screening Packages Columbia Asia Hospital - Miri (Valid until 31 December 2019) Get screened and track the cancer level at Columbia Asia Hospital – Miri. Male
![Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases | Scientific Reports Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-65720-8/MediaObjects/41598_2020_65720_Fig1_HTML.png)
Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases | Scientific Reports
![Evaluating the efficacy of tumor markers CA 19-9 and CEA to predict operability and survival in pancreatic malignancies Evaluating the efficacy of tumor markers CA 19-9 and CEA to predict operability and survival in pancreatic malignancies](http://www.tropicalgastro.com/uploads/Untitlemscd-31.jpg)
Evaluating the efficacy of tumor markers CA 19-9 and CEA to predict operability and survival in pancreatic malignancies
![The prognostic value of serum CA 19-9 for patients with advanced lung adenocarcinoma | BMC Cancer | Full Text The prognostic value of serum CA 19-9 for patients with advanced lung adenocarcinoma | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-016-2897-6/MediaObjects/12885_2016_2897_Fig2_HTML.gif)
The prognostic value of serum CA 19-9 for patients with advanced lung adenocarcinoma | BMC Cancer | Full Text
![CA 19-9 level in different T stages, grades, depth of invasion, and in... | Download Scientific Diagram CA 19-9 level in different T stages, grades, depth of invasion, and in... | Download Scientific Diagram](https://www.researchgate.net/publication/225044947/figure/tbl1/AS:202694657613824@1425337580006/CA-19-9-level-in-different-T-stages-grades-depth-of-invasion-and-in-metastatic.png)
CA 19-9 level in different T stages, grades, depth of invasion, and in... | Download Scientific Diagram
Enhanced Discrimination of Malignant from Benign Pancreatic Disease by Measuring the CA 19-9 Antigen on Specific Protein Carriers | PLOS ONE
![The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal - Ballehaninna - Journal of Gastrointestinal Oncology The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal - Ballehaninna - Journal of Gastrointestinal Oncology](https://cdn.amegroups.cn/journals/pbpc/files/journals/1/articles/181/public/181-PB15-4535-R1.png/w300)
The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal - Ballehaninna - Journal of Gastrointestinal Oncology
![The clinical utility of normal range carbohydrate antigen 19-9 level as a surrogate marker in evaluating response to treatment in pancreatic cancer-a report of two cases. | Semantic Scholar The clinical utility of normal range carbohydrate antigen 19-9 level as a surrogate marker in evaluating response to treatment in pancreatic cancer-a report of two cases. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/774e78614b2aab775f3493d19d9ef2cdd99429ad/3-Table1-1.png)
The clinical utility of normal range carbohydrate antigen 19-9 level as a surrogate marker in evaluating response to treatment in pancreatic cancer-a report of two cases. | Semantic Scholar
![The Highest Ever Reported Level of Carbohydrate Antigen 19-9: A Case Report | Al-Khallaf | Journal of Medical Cases The Highest Ever Reported Level of Carbohydrate Antigen 19-9: A Case Report | Al-Khallaf | Journal of Medical Cases](https://www.journalmc.org/tables/jmc142w-g004.jpg)
The Highest Ever Reported Level of Carbohydrate Antigen 19-9: A Case Report | Al-Khallaf | Journal of Medical Cases
![Frontiers | Value of Carbohydrate Antigen 19-9 in Predicting Response and Therapy Control in Patients with Metastatic Pancreatic Cancer Undergoing First-Line Therapy Frontiers | Value of Carbohydrate Antigen 19-9 in Predicting Response and Therapy Control in Patients with Metastatic Pancreatic Cancer Undergoing First-Line Therapy](https://www.frontiersin.org/files/Articles/52319/fonc-03-00155-HTML/image_m/fonc-03-00155-g001.jpg)